EQRxNews Page EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progress EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate ProgressArboretum_JDFebruary 23, 2023
Home PageNews PageStrata Oncology Strata Oncology Announces Publication of Study Validating Clinical Utility of Pan-tumor Predictive Biomarker for Checkpoint Inhibitor Immunotherapy Benefit Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, today…Arboretum_JDFebruary 7, 2023
Francis MedicalNews Page Francis Medical Appoints Andrew Cleeland to Board of Directors Francis Medical, Inc., a privately-held medical device company developing an innovative and proprietary water vapor…Arboretum_JDJanuary 26, 2023
JUMPCODE GenomicsNews Page Jumpcode Genomics joins PacBio Compatible Program Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology,…Arboretum_JDJanuary 12, 2023
Home PageNews PageNewsletter Arboretum Ventures Newsletter – Special 20th Anniversary Edition View the latest news and updates from Arboretum Ventures.Arboretum_JDJanuary 6, 2023
BrightSpecHome PageNews Page BrightSpec Announces $18.4 Million Financing Round Led by Genoa Ventures and Arboretum Ventures BrightSpec, Inc., a life science tools company commercializing Molecular Rotational Resonance (MRR) spectroscopy, announced today…Arboretum_JDDecember 14, 2022
EQRxNews Page EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency Application is based on data from the pivotal Phase 3 AENEAS trial evaluating aumolertinib as…Arboretum_JDDecember 2, 2022
News PageRareCyte RareCyte® selected for the Wellcome Leap In Utero program RareCyte Inc., ("RareCyte" or "The Company") a leading provider of Precision Biology products and services…Arboretum_JDNovember 16, 2022
Fifth EyeNews Page Fifth Eye Announces Andrew Malcolmson as new President & CEO Fifth Eye™, a leading provider of real-time AI-based clinical analytics today announced that its Board…Arboretum_JDNovember 2, 2022
Boomerang MedicalHome PageNews Page Bioelectronic Medicine Company Boomerang Medical Raises $15M in Series A Financing Returning investor Arboretum Ventures, joined by Hatteras Venture Partners, to fuel Boomerang Medical’s accelerated clinical…Arboretum_JDNovember 1, 2022